Collaboration between industry and regulators is critical to building a sector that is safe, patient-centred, and stable. Conversations like these are an important step forward. The key issues explored by the panel underscored the complexity of balancing patient access with regulatory integrity and the importance of bringing diverse voices to the table. Thanks to Teresa Nicoletti and the panel for this thoughtful, solutions-focused discussion.
In the latest episode of Cannabiz in Conversation, released today, industry leaders speak about the “high human cost” of limiting patient access to medicinal cannabis — calling for a more balanced and proportionate approach to addressing sector concerns while protecting those who rely on treatment. Watch now on Cannabiz 👇 https://lnkd.in/gsRScpFF #Cannabiz #MedicinalCannabis #Healthcare #CannabizinConversation Nick Lintzeris Teresa Nicoletti Martin Lane Priya Ayyar Kristin Viccars Medicinal Cannabis Industry Australia Australian Medicinal Cannabis Association